News & Insights

HMC Capital End of Year 2023

HMC Capital (ASX: HMC) Group Managing Director & CEO, David Di Pilla, reflects on a record year of growth for the Group.

We look back on 2023 to celebrate the Group’s achievements, including successfully closing over $2bn in our unlisted Institutional funds and the acquisition of the $1.2bn Healthscope hospital portfolio. Our private equity vehicle, HMC Capital Partners, ended the year with strong momentum with our portfolio company Sigma Healthcare announcing a transformational merger proposal with Chemist Warehouse, one of Australia’s largest and most successful retailers.

The HMC Capital team extends warm wishes for a safe and joyful festive season to all.

InBrief With David Di Pilla - February 2023

HMC Capital Managing Director and Group CEO, David Di Pilla, presented at The Inside Network's, Alternatives Symposium in Sydney. David’s presentation highlighted the increasing importance of portfolio allocation to high quality and non-correlated alternative assets. He also discussed the growing difficulty individual investors face in accessing alternative assets going forward given the wave of public to private activity that has taken place in Australia in recent times.

InDepth with Victoria Hardie - June 2023

Victoria Hardie, Managing Director - HMC Capital Partners, was recently interviewed by Peter White, The Inside Network.

Victoria's InDepth interview with Peter White covers the origins of HMC Capital Partners, investing in high-conviction, scalable real asset strategies and taking a proactive approach to investments.